Search results for "double-blind"

showing 10 items of 662 documents

Effectiveness of a spray containing 1% malic acid in patients with xerostomia induced by graft-versus-host disease

2018

Background To evaluate the clinical effectiveness of a topical sialogogue spray (malic acid, 1%) in the treatment of xerostomia in patients with chronic Graft versus Host Disease (cGVHD). Material and Methods This study was designed as a randomized double-blind clinical study. Twenty-eight patients with cGVHD suffering from xerostomia were divided into 2 groups: the first group (14 patients) received a topical sialagogue spray containing malic acid 1% (SalivAktive®) whereas the second group (14 patients) received a placebo. Both groups received treatment for 2 weeks. Dry Mouth Questionnaire (DMQ) scores and unstimulated salivary flows rate were collected before and after treatment. Results …

MaleMalatesGraft vs Host DiseaseGastroenterologylaw.inventionchemistry.chemical_compound0302 clinical medicineRandomized controlled triallawSurveys and QuestionnairesMalic acidSialogogueMalic acid; Transplantation; XerostomiaOtorhinolaryngology2734 Pathology and Forensic MedicineMiddle AgedMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]Treatment OutcomeUNESCO::CIENCIAS MÉDICASFemalemedicine.symptomOral SpraysSalivationAdultmedicine.medical_specialtyClinical effectivenessmalic acidPlaceboXerostomia03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansIn patientSalivaGeneral DentistryTransplantationbusiness.industryResearchXerostomia; malic acid; transplantation; Surgery; Otorhinolaryngology2734 Pathology and Forensic Medicine; Dentistry (all)030206 dentistrymedicine.diseaseDry mouthGraft-versus-host diseaseOtorhinolaryngologychemistryDentistry (all)SurgeryMalic acidbusinesstransplantation
researchProduct

Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)…

2015

AbstractThe polyphenol quercetin may prevent CVD due to its antihypertensive and vasorelaxant properties. We investigated the effects of quercetin after regular intake on blood pressure (BP) in overweight-to-obese patients with pre-hypertension and stage I hypertension. In addition, the potential mechanisms responsible for the hypothesised effect of quercetin on BP were explored. Subjects (n 70) were randomised to receive 162 mg/d quercetin from onion skin extract powder or placebo in a double-blinded, placebo-controlled cross-over trial with 6-week treatment periods separated by a 6-week washout period. Before and after the intervention, ambulatory blood pressure (ABP) and office BP were m…

MaleMedicine (miscellaneous)Blood PressureBody Mass IndexPrehypertensionchemistry.chemical_compoundOnionsInsulinheterocyclic compoundsCross-Over StudiesNutrition and DieteticsbiologyFull PapersBlood Pressure Monitoring AmbulatoryMiddle AgedCardiovascular diseasesC-Reactive ProteinCholesterolTreatment OutcomeHypertensionBody CompositionQuercetinFemaleWaist CircumferenceQuercetinHuman and Clinical NutritionAdultmedicine.medical_specialtyMean arterial pressureAmbulatory blood pressurePlaceboPrehypertensionDouble-Blind MethodInternal medicinemedicineHumansObesityAntihypertensive AgentsTriglyceridesAgedPlant Extractsbusiness.industryBody WeightEndothelial functionAngiotensin-converting enzymeOverweightEndocrinologyBlood pressurechemistryDietary Supplementsbiology.proteinPatient ComplianceEndothelium VascularEnergy IntakeAsymmetric dimethylargininebusinessBiomarkersBritish Journal of Nutrition
researchProduct

Altilix

2019

The objective was to evaluate the effects of 6 months of supplementation with Altilix®, containing chlorogenic acid and its derivatives, and luteolin and its derivatives, on cardiovascular risk and hepatic markers in subjects with metabolic syndrome (MetS). A randomized, double-blind, placebo-controlled study was performed in 100 subjects with MetS with a follow-up period of 6 months; 50 subjects were randomized to Altilix® (26 men and 24 women, mean age 63 ± 8 years) and the other 50 to placebo (28 men and 22 women, mean age 63 ± 11 years). Anthropometric, cardiometabolic, and hepatic parameters were assessed at baseline and at the end of follow-up. Carotid intima-media thickness and endot…

MaleMetabolic Syndromecynaranon-alcoholic fatty liver diseaseMiddle AgedArticlecardiovascular diseasesdietary supplementsDouble-Blind MethodLivertype 2Risk Factorsdiabetes mellitusHumansFemaleChlorogenic AcidLuteolinBiomarkersAgedNutrients
researchProduct

Effect of the local administration of betamethasone on pain, swelling and trismus after impacted lower third molar extraction. A randomized, triple b…

2013

Objectives: The aim of this study is to compare the analgesic and anti-inflammatory effects of the local postoperative administration of a single 12-mg dose of betamethasone after the surgical removal of impacted lower third molars. Study Design: A split-mouth, triple-blind, randomized, placebo-controlled clinical trial of 25 patients requiring the surgical removal of symmetrical lower third molars was performed. In the experimental side, a 12-mg dose of betamethasone was administered submucosally after the surgical procedure, while in the control side a placebo (sterile saline solution) was injected in the same area. To assess postoperative pain, visual analogue scales and the consumption …

MaleMolarAdministration TopicalAnti-Inflammatory AgentsTrismusBetamethasonelaw.inventionPostoperative ComplicationsClinical trialsRandomized controlled triallawEdemaAntiinflammatory agentsEdemaTeeth extractionMedicineProspective StudiesExtracció dentalPain PostoperativeAnalgesicsTooth ImpactedAgents antiinflamatorisDent molar:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludAnesthesiaUNESCO::CIENCIAS MÉDICASBetamethasoneFemaleOral Surgerymedicine.symptommedicine.drugmedicine.medical_specialtyAnalgesicOdontologíaPlaceboYoung AdultAnalgèsicsDouble-Blind MethodHumansGeneral Dentistrybusiness.industryResearchMolarSurgeryClinical trialOtorhinolaryngologyTooth ExtractionMolar ThirdTrismusSurgerybusinessAssaigs clínicsMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Effects of localmelatonin application on post-extraction sockets after third molar surgery: a pilot study

2014

Objectives: The purpose of this study was to assess the anti-inflammatory, analgesic and osteogenic early effects of melatonin on post-extraction sockets ofpatients requiring third molars extraction. Study Design: A randomized, triple-blind clinical trial was made using a split-mouth design. Both lower third molars of 10 patients were extracted and 3 mg of local melatonin or placebo were applied. Concentrations of interleukin-6 and nitrotyrosine were determined on samples of the clot from the socket by independent ELISA tests. Radiographic bone density was evaluated by measuring Hounsfield Units in panoramic and cross sections obtained by digital scanner. Statistycal analysis by Kolmogorov-…

MaleMolarBone densityAdministration TopicalRadiographyDentistryPilot ProjectsOdontologíaPlaceboMelatoninYoung Adultchemistry.chemical_compoundDouble-Blind MethodBone DensityHounsfield scalemedicineHumansTooth SocketGeneral DentistryDental alveolusMelatoninInterleukin-6business.industryResearchNitrotyrosine:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludOtorhinolaryngologychemistryTooth ExtractionUNESCO::CIENCIAS MÉDICASFemaleMolar ThirdSurgeryOral Surgerybusinessmedicine.drug
researchProduct

Prospective double-blind clinical trial evaluating the effectiveness of Bromelain in the third molar extraction postoperative period

2014

Objectives: To evaluate the anti-inflammatory and analgesic effect of Bromelain (pineapple extract) administered orally in the postoperative after extraction of impacted lower molars. Study Design: This is a prospective, placebo-controlled, unicentric, double-blind study; the sample size was 34 patients. The pre and postoperative outcomes, evaluated on the third (D3) and eighth day (D8), included inflamtion, pain and oral aperture, as well as the need for analgesics. One group received bromelain 150mg per day for three days and 100mg on days 4 to 7. The other group received placebo in the same dosage. All outcomes werrecorded quantitatively and analyzed with the Mann-Whitney U test for inde…

MaleMolarBromelain (pharmacology)Tooth extractionDentistryOdontologíaPlacebolaw.inventionClinical studyYoung AdultBromelinePostoperative ComplicationsDouble-Blind MethodRandomized controlled triallawThird molarPostoperative periodHumansMedicineProspective StudiesProspective cohort studyGeneral DentistryInflammationPain Postoperativebusiness.industryResearch:CIENCIAS MÉDICAS [UNESCO]BromelainsCiencias de la saludClinical trialOtorhinolaryngologySample size determinationAnesthesiaUNESCO::CIENCIAS MÉDICASTooth ExtractionMann–Whitney U testFemaleMolar ThirdTrismusSurgeryOral Surgerybusiness
researchProduct

Efficacy of methylprednisolone on pain, trismus and quality of life following surgical removal of mandibular third molars: a double-blind, split-mout…

2021

Background The objective of the present study was to compare the efficacy of different doses of methylprednisolone on postoperative sequelae and quality of life (QoL) following surgical removal of mandibular third molars (SRM3). Material and Methods Fifty-two patients (16 men and 36 women, mean age 25.9 years, range: 18-39) with bilateral impacted mandibular third molars were randomly allocated into intraoperative muscular injection of either 20mg, 30mg, 40mg methylprednisolone or saline injection. Baseline measurements were obtained preoperatively and compared with assessment after one day, three days, seven days and one month. Pain and trismus were estimated by visual analog scale score a…

MaleMolarTrismuslaw.inventionQuality of lifeRandomized controlled triallawEdemapainProspective StudiesperiodontitisGeneralized estimating equationUNESCO:CIENCIAS MÉDICASPain PostoperativedentistryTooth ImpactedMethylprednisoloneFemaleOral Surgerymedicine.symptomgingivitismedicine.drugAdultmedicine.medical_specialtyAdolescentreviewPlaceboMethylprednisolonemandibletrismusYoung AdultDouble-Blind Methodtooth lossmedicineCorticosteroidsHumansthird molarsleepGeneral Dentistrybusiness.industryResearchcase control studymethylprednisoloneConfidence intervalSurgeryOtorhinolaryngologyTooth ExtractionQuality of Lifeoral healthMolar ThirdTrismusSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Preemptive analgesic effectiveness of oral ketorolac plus local tramadol after impacted mandibular third molar surgery

2010

Objective: The aim of this study was to compare preemptive analgesia of oral ketorolac plus submucous local placebo with oral ketorolac plus submucous local tramadol after impacted mandibular third molar surgery. Study design: A double-blind, randomized, placebo-controlled clinical trial was conducted. Patients were randomized into two treatment groups (n = 15 per group): group A, oral ketorolac 10 mg, 30 minutes before surgery plus submucous local placebo (1 mL saline solution); group B, oral ketorolac 10 mg, 30 minutes before surgery plus submucous local tramadol (50 mg diluted in 1 mL saline solution). We evaluated the intensity of pain, time for the first analgesic rescue medication, an…

MaleMolarmedicine.medical_specialtyAdministration Topicalmedicine.medical_treatmentAnalgesicAdministration OralPlacebolaw.inventionYoung AdultDouble-Blind MethodRandomized controlled triallawStatistical significancemedicineHumansGeneral DentistrySalineTramadolPain Postoperativebusiness.industryAnti-Inflammatory Agents Non-SteroidalTooth Impacted:CIENCIAS MÉDICAS [UNESCO]SurgeryAnalgesics OpioidKetorolacOtorhinolaryngologyAnesthesiaUNESCO::CIENCIAS MÉDICASDrug Therapy CombinationFemaleMolar ThirdSurgeryTramadolbusinessKetorolacmedicine.drug
researchProduct

Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of he…

2015

Background: To evaluate, in an initial way, the effectiveness of bioadhesive chlorhexidine gel 0.2% versus placebo as a preventive and therapeutic intervention of oral mucositis induced by radiation therapy and chemotherapy in patients diagnosed with head and neck cancer treated with chemoradiotherapy. Material and Methods: In this pilot study, 7 patients (range of age: 18- 65), having histological documented diagnosis of squamous carcinoma on the head and neck region in stage III and IV, and receiving combined radiation treatment and chemotherapy (cisplatin 100 mg/m2 IV on days 1, 22, and 43 of irradiation) were studied. Simultaneously, a topical application was performed with bioadhesive …

MaleMucositismedicine.medical_specialtymedicine.medical_treatmentOdontologíaBiocompatible MaterialsPilot ProjectsPlaceboHead and neck cancer.Double-Blind MethodmedicineMucositisHumansProspective StudiesGeneral DentistryChemotherapyStomatitisbusiness.industryResearchHead and neck cancerChlorhexidineChlorhexidineChemoradiotherapyMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludSurgerySquamous carcinomaRadiation therapyOtorhinolaryngologyHead and Neck NeoplasmsUNESCO::CIENCIAS MÉDICASAnti-Infective Agents LocalSurgeryFemaleTissue AdhesivesOral SurgerybusinessGelsChemoradiotherapymedicine.drugMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis

2008

Objective: To prospectively validate MRI activity and neutralising anti-interferon antibody (NAb) during the first 6 months of interferon β treatment as response indicators in multiple sclerosis (MS). Methods: Patients with relapsing–remitting MS were followed during the first 2 years of treatment. Neurological assessments were performed every 3 months or when a relapse was suspected. MRI scans performed at baseline and at 3, 4, 5 and 6 months after the start of treatment were assessed centrally for disease activity: new T2 or gadolinium enhancing T1 lesions. NAb were assessed using the MxA protein assay; positivity was defined as two consecutive titres ⩾20 NU/ml. We evaluated the predictiv…

MaleNeutralising antibodyMULTICENTERPLACEBO-CONTROLLED TRIALGUIDELINESGastroenterologyDOUBLE-BLINDInterferon βMAGNETIC-RESONANCEProspective StudiesNeurologic ExaminationbiologyBrainIMPAIRMENTMiddle AgedPredictive valueMagnetic Resonance ImagingRecombinant ProteinsPsychiatry and Mental healthTreatment OutcomeSettore MED/26 - NeurologiaFemaleAntibodyInterferon beta-1bAdultmedicine.medical_specialtyDIAGNOSTIC-CRITERIAInjections SubcutaneousAntibodiesDrug Administration ScheduleDisease activityMultiple Sclerosis Relapsing-RemittingAdjuvants ImmunologicNeutralization TestsInternal medicinemedicineHumansInterferon betabusiness.industryMultiple sclerosisDISABILITYMSInterferon-betamedicine.diseaseConfidence intervalSurgerybiology.proteinSurgeryNeurology (clinical)businessFollow-Up Studies
researchProduct